Nilotinib Hydrochloride Monohydrate
Who holds supplier records for Nilotinib Hydrochloride Monohydrate? 8 organisations hold a current record for Nilotinib Hydrochloride Monohydrate: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6) and China (2).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Nilotinib Hydrochloride Monohydrate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/nilotinib-hydrochloride-monohydrate
Reading the evidence
- 8 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
6 of the 8 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (8)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Nilotinib Hydrochloride Monohydrate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 37161 · latest filing Jul 2022
- Shandong Lixin Pharmaceutical Co., Ltd.ChinaCEPActive DMF 40014 · latest filing May 2024
- AARTI PHARMALABS LIMITEDIndiaActive DMF 42588 · latest filing Apr 2026
- GRANULES INDIA LTD (UNIT-V)IndiaActive DMF 37531 · latest filing Sept 2022
- Natco PharmaIndia Company GMP cert on recordActive DMF 36308 · latest filing Dec 2022
- Suzhou Lixin Pharmaceutical Co., Ltd.ChinaActive DMF 31693 · latest filing Apr 2017
- IndiaCEP Company GMP cert on record
- IndiaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Nilotinib Hydrochloride Monohydrate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 7 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| RAVI BIOLIFE PRIVATE LIMITED Mumbai | IN | CEP 2022-425 - Rev 02 Nilotinib hydrochloride monohydrate | Oct 2026 | — |
| SHANDONG LIXIN PHARMACEUTICAL CO. LTD. Zibo | CN | CEP 2021-133 - Rev 02 Nilotinib hydrochloride monohydrate | Sept 2026 | — |
| MSN LABORATORIES PRIVATE LIMITED Sangareddy | IN | CEP 2026-103 - Rev 00 Nilotinib hydrochloride monohydrate, Route code-NPH, Crystalline Form-B | Jun 2026 | Inspected Aug 2026 Slovakia |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2023-226 - Rev 00 Nilotinib hydrochloride monohydrate, Form-B | Jan 2026 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Nilotinib Hydrochloride Monohydrate are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- Zhejiang Jiuzhou Pharmaceutical Co., Ltd.China · Inactive DMF 25412, 25338 · filed Oct 2011
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Nilotinib Hydrochloride Monohydrate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201740).
Chemical identity
- IUPAC name
- 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide;hydrate;hydrochloride
- Canonical SMILES
- CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.O.Cl
- InChIKey
- YCBPQSYLYYBPDW-UHFFFAOYSA-N
- Synonyms
- Nilotinib (as hydrochloride), Nilotinib hydrochloride, Nilotinib hydrochloride anhydrous, Nilotinib hydrochloride hydrate, Nilotinib hydrochloride monohydrate, Tasigna, Nilotinib monohydrochloride monohydrate, Nilotinib hydrochloride hydrate [JAN], Nilotinib hydrochloride hydrate (JAN), NILOTINIB HYDROCHLORIDE MONOHYDRATE [MI], RefChem:854151, 641571-10-0, Nilotinib
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Kinase Inhibitor
- Mechanism of action
- Bcr-Abl Tyrosine Kinase Inhibitors; Cytochrome P450 2B6 Inducers; Cytochrome P450 2C8 Inducers; Cytochrome P450 2C8 Inhibitors; Cytochrome P450 2D6 Inhibitors; P-Glycoprotein Inhibitors; UGT1A1 Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Nilotinib Hydrochloride Monohydrate?
8 organisations hold an active US FDA Type II Drug Master File or a CEP for Nilotinib Hydrochloride Monohydrate: Dr. Reddy's Laboratories Ltd. (India), Shandong Lixin Pharmaceutical Co., Ltd. (China), AARTI PHARMALABS LIMITED (India), GRANULES INDIA LTD (UNIT-V) (India), Natco Pharma (India), Suzhou Lixin Pharmaceutical Co., Ltd. (China), MSN Laboratories Private Limited (India) and RAVI BIOLIFE PRIVATE LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Nilotinib Hydrochloride Monohydrate Drug Master Files are active?
Dr. Reddy's Laboratories Ltd. (DMF 37161), Shandong Lixin Pharmaceutical Co., Ltd. (DMF 40014), AARTI PHARMALABS LIMITED (DMF 42588), GRANULES INDIA LTD (UNIT-V) (DMF 37531), Natco Pharma (DMF 36308) and Suzhou Lixin Pharmaceutical Co., Ltd. (DMF 31693). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Nilotinib Hydrochloride Monohydrate records mean?
1 organisation has only inactive Type II DMFs for Nilotinib Hydrochloride Monohydrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Nilotinib Hydrochloride Monohydrate have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Nilotinib Hydrochloride Monohydrate on the EDQM register, including RAVI BIOLIFE PRIVATE LIMITED Mumbai (IN), SHANDONG LIXIN PHARMACEUTICAL CO. LTD. Zibo (CN), MSN LABORATORIES PRIVATE LIMITED Sangareddy (IN) and DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Nilotinib Hydrochloride Monohydrate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Nilotinib Hydrochloride Monohydrate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.